Tysabri Touch Program

While many people may find
 Tysabri® (natalizumab) an effective treatment for Crohn's disease or multiple sclerosis (MS), there are some potentially serious and even life-threatening complications this drug can cause. Some of these problems may include a serious brain infection, liver damage, and severe allergic reactions.
 
Due to these risks, you can only receive Tysabri through a special program called the Touch® program. You, your healthcare provider, and the infusion center where you receive your dose must be enrolled in this program. The Touch program ensures you understand the risks and benefits of receiving Tysabri. Your healthcare provider will help you enroll in this program, and will talk to you about Tysabri treatment.
 
(For more information, click Tysabri Warnings and Precautions. This eMedTV article also takes an in-depth look into other potentially serious complications this drug may cause and what you need to discuss with your healthcare provider prior to treatment.)
Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP
Last reviewed by: Kristi Monson, PharmD